Jane Street’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $527K | Sell |
96,700
-123,700
| -56% | -$694K | ﹤0.01% | 7929 |
|
|
2025
Q4 | $1.54M | Sell |
220,400
-582,000
| -73% | -$4.56M | ﹤0.01% | 5293 |
|
|
2025
Q3 | $6.2M | Buy |
802,400
+130,600
| +19% | +$1.02M | ﹤0.01% | 3093 |
|
|
2025
Q2 | $5.85M | Buy |
671,800
+199,300
| +42% | +$1.44M | ﹤0.01% | 2795 |
|
|
2025
Q1 | $3.76M | Buy |
472,500
+267,300
| +130% | +$2.7M | ﹤0.01% | 3351 |
|
|
2024
Q4 | $1.87M | Buy |
205,200
+20,200
| +11% | +$195K | ﹤0.01% | 4234 |
|
|
2024
Q3 | $1.7M | Sell |
185,000
-72,200
| -28% | -$598K | ﹤0.01% | 4816 |
|
|
2024
Q2 | $2.52M | Buy |
257,200
+84,200
| +49% | +$1.03M | ﹤0.01% | 4110 |
|
|
2024
Q1 | $2.61M | Sell |
173,000
-34,700
| -17% | -$630K | ﹤0.01% | 3643 |
|
|
2023
Q4 | $4.48M | Buy |
207,700
+20,200
| +11% | +$373K | ﹤0.01% | 3015 |
|
|
2023
Q3 | $3.49M | Buy |
187,500
+21,100
| +13% | +$493K | ﹤0.01% | 3144 |
|
|
2023
Q2 | $4.21M | Sell |
166,400
-62,000
| -27% | -$1.56M | ﹤0.01% | 2984 |
|
|
2023
Q1 | $5.92M | Sell |
228,400
-84,500
| -27% | -$2.26M | ﹤0.01% | 2216 |
|
|
2022
Q4 | $7.4M | Sell |
312,900
-484,300
| -61% | -$13.1M | ﹤0.01% | 1967 |
|
|
2022
Q3 | $20.2M | Sell |
797,200
-336,900
| -30% | -$11.8M | 0.01% | 1060 |
|
|
2022
Q2 | $37.7M | Sell |
1,134,100
-586,000
| -34% | -$24.9M | 0.02% | 690 |
|
|
2022
Q1 | $124M | Sell |
1,720,100
-107,700
| -6% | -$7.76M | 0.04% | 304 |
|
|
2021
Q4 | $168M | Buy |
1,827,800
+642,300
| +54% | +$76.8M | 0.06% | 225 |
|
|
2021
Q3 | $150M | Buy |
1,185,500
+122,300
| +12% | +$17.8M | 0.05% | 242 |
|
|
2021
Q2 | $177M | Buy |
1,063,200
+295,000
| +38% | +$47.8M | 0.07% | 190 |
|
|
2021
Q1 | $140M | Buy |
768,200
+490,131
| +176% | +$114M | 0.07% | 191 |
|
|
2020
Q4 | $55.6M | Buy |
278,069
+13,069
| +5% | +$2.66M | 0.03% | 422 |
|
|
2020
Q3 | $58.1M | Buy |
265,000
+74,100
| +39% | +$15.7M | 0.03% | 344 |
|
|
2020
Q2 | $36.4M | Buy |
190,900
+65,200
| +52% | +$11.4M | 0.03% | 471 |
|
|
2020
Q1 | $19.5M | Buy |
125,700
+104,900
| +504% | +$12.2M | 0.02% | 476 |
|
|
2019
Q4 | $1.74M | Sell |
20,800
-2,200
| -10% | -$167K | ﹤0.01% | 2100 |
|
|
2019
Q3 | $1.56M | Buy |
23,000
+15,800
| +219% | +$1.04M | ﹤0.01% | 2089 |
|
|
2019
Q2 | $478K | Sell |
7,200
-10,400
| -59% | -$606K | ﹤0.01% | 3639 |
|
|
2019
Q1 | $979K | Buy |
17,600
+5,000
| +40% | +$305K | ﹤0.01% | 2835 |
|
|
2018
Q4 | $625K | Buy |
+12,600
| New | +$771K | ﹤0.01% | 3179 |
|
|
2018
Q3 | – | Sell |
-17,500
| Closed | -$1.02M | – | 5696 |
|
|
2018
Q2 | $1.02M | Buy |
+17,500
| New | +$855K | ﹤0.01% | 2724 |
|
Other funds holding TDOC
VPM
VCM
VC
Jane Street's TDOC Position: Q1 2026 in Review
Jane Street reduced its Teladoc Health (TDOC) stake by 97% in Q1 2026, selling an estimated $4.8M and leaving 24,789 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #10467.
Jane Street first reported a position in TDOC in Q3 2016 and has held it in 32 quarters since. The position peaked at $108M in Q3 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.
- Jane Street held 24,789 shares of Teladoc Health worth $135K as of Q1 2026.
- Jane Street sold 855,025 Teladoc Health shares in Q1 2026, an estimated $4.8M.
- Teladoc Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10467 holding.
- Jane Street first reported a position in Teladoc Health in Q3 2016 and has held it in 32 quarters since.
- Jane Street's Teladoc Health position peaked at $108M in Q3 2021.
- 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.